DNMT3A and prostate adenocarcinoma: We analyzed the expression of DNMT1, DNMT3A, DNMT3B, and the class I HDACs HDAC1, HDAC2, HDAC3, and HDAC8 in the PRAD and Taylor data sets and their correlation to HLA-I expression in prostate cancer.